Signpost Capital Advisors, LP
Follow13F filer, CIK 1560812, New York, NY
Signpost Capital Advisors, LP reported $81,670,000 across 9 holdings for the quarter ended 2016-12-31, in a 13F-HR filed 2017-02-13.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001560812-17-000001
Changes against Q3 2016 are not shown: its report omitted holdings under a confidential treatment request (12 positions on file), so every position would read as new.
The filing omits holdings under a confidential treatment request (H8). A later amendment may add them.
- Period
- 2016-12-31
- Reported value
- $81.7M
- Holdings
- 9
- Top 10 weight
- 100%
- New
- Sold out
Holdings, Q4 2016
Share positions as resolved from 13F-HR 0001560812-17-000001, largest first. % of portfolio is the value over $81,670,000, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| KRAFT HEINZ COKRAFT HEINZ CO | 277,000 | $24.2M | 29.62% | The filing omitted confidential holdings, a later amendment may add them. | |||
| CALPINE CORPCALPINE CORP | 1,541,173 | $17.6M | 21.57% | The filing omitted confidential holdings, a later amendment may add them. | |||
| CALPINE CORPCALPINE CORP | 765,000 | $8.74M | 10.71% | The filing omitted confidential holdings, a later amendment may add them. | |||
| TRIPTRIPADVISOR INC | 183,300 | $8.5M | 10.41% | The filing omitted confidential holdings, a later amendment may add them. | Timeline | ||
| DVADAVITA INC | 114,776 | $7.37M | 9.02% | The filing omitted confidential holdings, a later amendment may add them. | Timeline | ||
| SRGSERITAGE GROWTH PPTYS | 167,500 | $7.15M | 8.76% | The filing omitted confidential holdings, a later amendment may add them. | Timeline | ||
| MEDICINES COMEDICINES CO | 110,883 | $3.76M | 4.61% | The filing omitted confidential holdings, a later amendment may add them. | |||
| RETROPHIN INCRETROPHIN INC | 163,741 | $3.1M | 3.8% | The filing omitted confidential holdings, a later amendment may add them. | |||
| ALNYALNYLAM PHARMACEUTICALS INC | 33,065 | $1.24M | 1.52% | The filing omitted confidential holdings, a later amendment may add them. | Timeline |
How Q4 2016 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001560812-17-000001 | base | 2017-02-13 | acceptance time not in the bulk data set |